Status:
COMPLETED
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
Lead Sponsor:
Donald Mathews
Collaborating Sponsors:
Respiratory Motion, Inc.
Conditions:
Biliary Tract Diseases
Stomach Neoplasms
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Purpose: To assess the utility of a new medical device that monitors a patient's breathing during medical procedures in which a patient is sedated, but not mechanically ventilated. In minor procedures...
Detailed Description
The purpose of this study is to assess the utility of the ExSpiron Respiratory Variation Monitor in patients undergoing an interventional procedure with anesthesia. The primary outcome measure will be...
Eligibility Criteria
Inclusion
- Subjects undergoing upper gastrointestinal endoscopy
Exclusion
- Patients with a history of thoracotomy with resection of lung tissue
- Patients with a history of severe chronic obstructive pulmonary disease (defined as an inability to climb a flight of stairs or FEV1/VC of less than 30% of predicted)
- BMI greater than 43.
Key Trial Info
Start Date :
September 22 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02310230
Start Date
September 22 2014
End Date
May 9 2016
Last Update
June 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Vermont Medical Center
Burlington, Vermont, United States, 05401